uniQure N.V. (QURE) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Uniqure N.v..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.136 All participants are in a listen-only mode. 00:00:03.136 -- 00:00:07.023 After the speaker's remarks, we will conduct a question and answer session. 00:00:07.023 -- 00:00:10.448 To ask a question at this time, you'll need to press star followed by the number one 00:00:10.448 -- 00:00:12.752 on your telephone keypad. 00:00:12.752 -- 00:00:14.896 As a reminder, this conference call is being recorded. 00:00:14.896 -- 00:00:19.944 I would now like to turn the call over to Kiara Russo, Senior Director 00:00:19.944 -- 00:00:23.647 of Investor Relations. Thank you. Please go ahead. 00:00:24.533 -- 00:00:29.840 Good morning, and thank you for joining us for Unicure's third quarter of 2025 earnings 00:00:29.840 -- 00:00:34.867 call. Earlier this morning, Unicure released its financial results for the third quarter 00:00:34.867 -- 00:00:39.733 of 2025, and our press release is available on the investors and media section of our 00:00:39.733 -- 00:00:42.857 website at unicure.com. 00:00:42.857 -- 00:00:47.643 Our 10Q was also filed with the SEC earlier today. 00:00:47.643 -- 00:00:52.837 Joining me on the call this morning are Matt Capista, Chief Executive Officer, Dr. 00:00:52.837 -- 00:00:57.902 Walid Abisab, Chief Medical Officer, Kylie O'Keefe, Chief Customer 00:00:57.902 -- 00:01:02.147 and Strategy Officer, and Christian Klempt, Chief Financial Officer. 00:01:02.147 -- 00:01:06.731 After our formal remarks, we'll open the call-up for Q&A. 00:01:06.731 -- 00:01:10.575 Before we begin, please know that we will be making forward-looking statements during 00:01:10.575 -- 00:01:15.740 this investor call. All statements other than statements of historical fact are forward-looking 00:01:15.740 -- 00:01:20.504 statements. They are based on mana...